TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+5.11%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$64M
(+2.5%)
Cap. Flow
-$37M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
198
New
11
Increased
45
Reduced
37
Closed
18
Top Buys
| 1 |
UnitedHealth
UNH
|
$17.9M |
| 2 |
Stryker
SYK
|
$12.2M |
| 3 |
AstraZeneca
AZN
|
$11.8M |
| 4 |
Danaher
DHR
|
$11.6M |
| 5 |
Pfizer
PFE
|
$11.2M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$19M |
| 2 |
SHPG
Shire pic
SHPG
|
$13.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.2M |
| 4 |
Abbott
ABT
|
$10.5M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$8.69M |
Sector Composition
| 1 | Healthcare | 92.61% |
| 2 | Real Estate | 3% |
| 3 | Financials | 0.68% |
